Protirakovinný účinek melatoninu s radioprotektivní a radiosenzitivní vlastností

Stiahnuť PDF English version

Autori: Benderli Yasemin Cihan
Pôsobisko autorov: Department of Radiation Oncology, Kayseri Education and Research Hospital, Turkey
Vyšlo v časopise: Klin Onkol 2020; 33(2): 150-151
Kategória: Krátké sdělení
doi: https://doi.org/10.14735/amko2020150

Zdroje

1. Pourhanifeh MH, Mahdavinia M, Reiter RJ et al. Potential use of melatonin in skin cancer treatment: a review of current biological evidence. J Cell Physiol 2019; 234 (8): 12142–12148. doi: 10.1002/jcp.28129.

2. Vural EM, van Munster BC, de Rooij SE. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature. Drugs Aging 2014; 31 (6): 441–451. doi: 10.1007/s40266-014-0178-0.

3. Wang Q, Sun Z, Du L et al. Melatonin sensitizes human colorectal cancer cells to γ-ray ionizing radiation in vitro and in vivo. Int J Mol Sci 2018; 19 (12): 3974. doi: 10.3390/ijms19123974.

4. Reiter RJ, Tan DX, Terron MP et al. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007; 54 (1): 1–9.

5. Shabeeb D, Najafi M, Musa AE et al. Biochemical and histopathological evaluation of the radioprotective effects of melatonin against Gamma ray-induced skin damage in rats. Curr Radiopharm 2019; 12 (1): 72–81. doi: 10.2174/1874471012666181120163250.

6. Kouhi Habibi N, Shabestani Monfared A, Ebrahimnejad Gorji K et al. The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial. Clin Transl Oncol 2019; 21 (6): 745–752. doi: 10.1007/s12094-018-1977-2.

7. Menéndez-Menéndez J, Martínez-Campa C. Melatonin: an anti-tumor agent in hormone-dependent cancers. Int J Endocrinol 2018; 2018: 3271948. doi: 10.1155/2018/3271948.

8. Farhood B, Goradel NH, Mortezaee K et al. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clin Transl Oncol 2019; 31 (3): 268–279. doi: 10.1007/s12094-018-1934-0.

9. Onseng K, Johns NP, Khuayjarernpanishk T et al. Beneficial effects of adjuvant melatonin in minimizing oral mucositis complications in head and neck cancer patients receiving concurrent chemoradiation. J Altern Complement Med 2017; 23 (12): 957–963. doi: 10.1089/acm.2017.0081.

10. Ben-David MA, Elkayam R, Gelernter I et al. Melatonin for prevention of breast radiation dermatitis: a phase II, prospective, double-blind randomized trial. Isr Med Assoc J 2016; 18 (3–4): 188–192.

11. Siu SW, Lau KW, Tam PC et al. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 2002; 52 (2): 106–122. doi: 10.1002/pros.10098.

12. Berk L, Berkey B, Rich T et al. Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). Int J Radiat Oncol Biol Phys 2007; 68 (3): 852–857. doi: 10.1016/j.ijrobp.2007.01.012.